Chandler Robinson - Chief Executive Officer, Director at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
MNPR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Chandler Robinson - trading volume in the past year for Monopar Therapeutics

Holdings reported by Chandler Robinson for Monopar Therapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 272K $13M $47.67 Sep 30, 2025 Indirect
Common Stock 79.6K $6.5M $81.67 Sep 30, 2025 Direct
Restricted Stock Units 72.6K $3.45M $36.41 Sep 30, 2025 Direct Common Stock
Stock Options 0 Jul 14, 2025 Direct Common Stock

Transactions reported by Chandler Robinson for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.